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ABSTRACT Theoretical methods are used to develop models for the ion channel structure of the membrane-bound amyloid
/-protein. This follows recent observations that the /-protein forms cation-selective channels in lipid bilayers in vitro. Amyloid
,/-protein is the main component of the extracellular plaques in the brain that are characteristic of Alzheimer's disease. Based
on the amino acid sequence and the unique environment of the membrane, the secondary structure of the 40-residue /-protein
is predicted to form a /-hairpin followed by a helix-turn-helix motif. The channel structures were designed as aggregates of
peptide subunits in identical conformations. Three types of models were developed that are distinguished by whether the pore
is formed by the /3-hairpins, the middle helices, or by the more hydrophobic C-terminal helices. The latter two types can be
converted back and forth by a simple conformational change, which would explain the variable conduction states observed for
a single channel. It is also demonstrated how lipid headgroups could be incorporated into the pore lining, and thus affect the
ion selectivity. The atomic-scale detail of the models make them useful for designing experiments to determine the real structure
of the channel, and thus further the understanding of peptide channels in general. In addition, if /3-protein-induced channel activity
is found to be the cause of cell death in Alzheimer's disease, then the models may be helpful in designing counteracting drugs.
INTRODUCTION
The occurrence of Alzheimer's disease is associated with vas-
cular and neuronal damage in the brain, involving the formation
of intraneuronal neurofibrillary tangles and the accumulation of
amyloid /3-protein (A/3P) in extracellular amyloid plaques
(Blessed et al., 1968; Neve et al., 1990; Katzman and Saitoh,
1991; Selkoe, 1991; McKee et al., 1991; Hardy and Higgins,
1992; Kosik, 1992). Accordingly, it has been suggested that A,P
is an important neurotoxic principle in the development of the
disorder, and many experiments have been devoted to testing this
hypothesis (Goldgaber et al., 1981; Tanzi et al., 1987; Joachim
et al., 1988; Goate et al., 1991; Pike et al., 1991; Barger et al.,
1993). Two concepts have emerged. The first is that A,BP tox-
icity may be synergistic with other agents, such as with the ex-
citatory amino acid glutamate (Koh et al., 1990; Mattson et al.,
1992), or by the binding to tachykinin receptors (Yankner et al.,
1990; Kimura and Schubert, 1993). The second, although not
exclusive, possibility is that A/P is toxic by itself (Neve et al.,
1990; Yankner et al., 1990), perhaps by raising the intracellular
concentration of calcium ions (Joseph and Han, 1992). Consis-
tent with the latter is our recent observation that A(BP[1-40]
forms "giant" cation-selective channels in lipid bilayers, with
conduction values as large as 5 nS (Arispe et al., 1993a, b;
Pollard et al., 1993).
Considerable effort has focused on determining the solu-
tion and solid-state structure of APP and its fragments to
better understand the extracellular plaques observed in vivo
(Muller-Hill and Beyreuther, 1989; Kirschner et al., 1987;
Halverson et al., 1990; Hilbich et al., 1991; Barrow and
Zagorski, 1991; Barrow et al., 1992; Burdick et al., 1992;
Inouye et al., 1993). In solution, A,BP assumes different pro-
portions of helix, /3-sheet, and random coil and different de-
grees of aggregation depending on the environmental con-
ditions. In the solid state, however, A,BP is generally
characterized by ,B-sheet structures. Unfortunately, the rel-
evance of these data to the conformation ofA,BP in the mem-
brane is not clear, because of the stratified hydrophilic/
hydrophobic environment of the bilayer. Instead, we based
our structure predictions on the amino acid sequence and its
relation to patterns observed in other membrane-bound and
channel-forming peptides and proteins. For example, the am-
phipathic pattern and turn sequence in the N-terminal region
suggest that this part of the sequence forms a /3-hairpin. Like-
wise, the hydrophobic character and transmembrane position
of the C-terminal region of A/3P in the precursor protein
(Kang et al., 1987) suggest that this part of the sequence
forms a membrane-embedded a-helix.
Previously, it has been demonstrated that similar ion channels
are formed when A/3P[1-40] is incorporated into artificial lipid
bilayers by either the liposome fusion technique or directly from
solution (Arispe et al., 1993a, b; Pollard et al., 1993). Single
channels are observed to convert within and between two con-
duction ranges: 40-400 pS and 0.4-5.0 nS. Both of these "large"
and "giant" sized channels are cation-selective; however, the
"giant" channel is considerably less susceptible to blockage by
tromethamine. Because of the suspected large physical size of
the channel structures, the models were designed as aggregates
of many membrane-bound A/3P subunits. The process used to
develop the models is an extension of our work with other chan-
nel forming peptides, which includes cecropin, magainin,
8-hemolysin, and pardaxin (Durell et al., 1992; Cruciani et al.,
1992; Raghunathan et al., 1990; Lazarovici et al., 1992) and is
a combination oftheoretical principles with experimental data on
the conductance of the channel.
Three basic types of channel models were developed. These
are distinguished by whether the pore is formed by a /3-barrel
(comprised of the N-terminal /3-hairpins) or by a grouping of the
middle and/or C-terminal helices. The latter two channel types
are interconvertible by a simple conformational change. This
alters the proportions of the pore and thus could explain the
observed "spontaneous" conduction changes. To examine the
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possible modes of peptide-membrane binding and channel for-
mation, some models were developed with lipid molecules in-
corporated into the structures. In this case, the specific confor-
mations and identities of the lipid headgroups would affect the
properties of the pore. It is hoped that the ideas embodied in these
models will prove useful in designing tests of AB3P and other
peptide channel structures. The coordinates are available from
the corresponding authors upon request.
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FIGURE 1 Amino acid sequence of AP3P[1-40]. The circles indicate the
charged residues, the underscores indicate the polar-neutral residues, and the
remaining residues are considered hydrophobic. The rectangles indicate pre-
dicted turn regions.
MATERIALS AND METHODS
Because current methods cannot calculate accurately the free energy of the
ion channel models, which would include interactions between the peptides,
lipids, solvent, and ions, a number of principles are used to construct struc-
tures that are expected to be thermodynamically stable. The main principle
requires positioning the polar and nonpolar amino acid residues in either
hydrophilic or hydrophobic environments, respectively. For the polar resi-
dues, this means limiting contact to other polar residues, the lipid head-
groups, and/or the solvent. This also results in maximizing the number of
stabilizing hydrogen bonds and salt-bridges. Likewise, the nonpolar residues
are limited to contact with other nonpolar residues and/or the alkyl chains
of the lipids. A second principle concerns the packing of the peptide sub-
units, such that unrealistic atomic overlaps and internal cavities are avoided.
This is achieved by optimizing the van der Waals energy.
The first assumption used in designing the models was that the channels
are formed from an assembly of A(3P[1-40] subunits. Otherwise, it is hard
to imagine how a single A(3P molecule, which is not quite long enough to
form two transmembrane helices, could form a channel structure responsible
for such large observed conductances (up to 5 nS). A second assumption was
that each subunit assumes the same conformation and that they are arranged
symmetrically around the axis of the pore. Although not unexpected on
energetic grounds, this restriction also simplifies the modeling procedure by
reducing the number of possible inter-subunit arrangements.
Once a basic structural motif was devised and built on the computer, an
iterative procedure of direct manipulation and automated energy minimi-
zation was used to refine the models in accord with the principles described
above. In particular, the Quanta computer program (Molecular Simulations,
Inc., Waltham, MA) was used to adjust the torsional angles into the desired
backbone and side-chain conformations, and the Minimization facility of the
CHARMM computer program (Brooks et al., 1983; Molecular Simulations)
was used to optimize the packing for that specific conformation (which
includes removing atomic overlap and tuning the salt-bridges and hydrogen
bonds). The minimization procedure typically consisted of 100 steps of
Steepest Descent followed by 300 steps ofAdopted Basis Newton-Raphson,
utilizing the residue topology and PARM30 parameters provided with the
commercial version of CHARMM. The Image facility was used for the
minimization of multimeric channel structures. It must be emphasized that
the purpose of the automated energy minimization was simply to optimize
the packing within the local minimum associated with the starting confor-
mation. No attempt was made to search for the "correct" conformation of
the protein with minimization and/or dynamics procedures, which would
require accurately representing the membrane and solvent environments and
sufficiently sampling the extremely large conformational space. For this
reason, only a simple distance-dependent dielectric constant was used for
the electrostatic interactions.
The concepts for the channel structure assemblies were developed from
the particular arrangement of secondary structure elements that we predicted
for Af3P[1-40] in a membrane/solvent environment, which is described
below. The sequence of A,BP used in the channel measurements is shown
in Fig. 1. Except for the histidines, the circles indicate those residues that
would be formally charged at the experimental conditions ofpH 7.0 and 7.4
(Arispe et al., 1993a, b; Pollard et al., 1993). Because this is only slightly
above the intrinsic pK. of the peptide-bound imidazole ring (-6.5-7.0), the
actual charged states of the histidines would be strongly influenced by
the local environment. The underscores indicate the polar-neutral residues.
The remaining residues are considered hydrophobic.
As pointed out by Kirschner et al. (1987), there are two regions within
the first 28 residues of the sequence that have a high propensity for pro-
ducing a turn in the 3-D structure (Chou and Fasman, 1978). These are
indicated by rectangular boxes in Fig. 1. The next most striking feature is
that the first turn segment is flanked on both sides by a short stretch of
alternating charged and hydrophobic residues. For a peptide bound in the
mixed hydrophilic/hydrophobic environment of a membrane, this type of
amphipathic pattern suggests that the first 13 residues of the sequence form
a (3-hairpin structure. The three-residue linker of the hairpin would likely
form some type of fy-turn structure (Sibanda et al., 1989; Rose et al., 1985).
After the second turn segment (second rectangle), the remaining residues
[28-40] are mostly nonpolar and are thus likely to be embedded in the
hydrophobic core of the membrane. In this case, and despite the extra-
flexible glycines, the sequence would likely adopt a helical conformation
to form hydrogen bonds and thus reduce the destabilizing effect of the
peptide backbone partial charges. It should be pointed out, however, that a
circular dichroism analysis of the AP3P[29-42] fragment in reduced polarity
solvent failed to detect appreciable amounts of helical secondary structure
(Barrow et al., 1992). However, the hydroxyl-group-containing trifluoro-
ethanol and hexafluoro-2-propanol solvents used in that study are still more
polar than the alkyl-chain core of a membrane. Furthermore, this C-terminal
region of A,BP has been identified as forming the outer half of the single
transmembrane domain of the amyloid precursor protein (Kang et al., 1987),
which would generally be believed to have a helical conformation. The
prediction for this region also corresponds with the occurrence of an as-
paragine at position 27, which is the most commonly observed residue found
at the N-terminal cap of helices in known protein structures (Richardson and
Richardson, 1988). Another interesting feature is that in a helical confor-
mation the four glycine residues at positions 29, 33, 37, and 38 would result
in an exposed band along one side of the helix. Finally, residues 16-24 were
postulated to form a second helix, which is in the middle of the sequence.
This was based on the Chou-Fasman prediction values (Chou and
Fassman, 1978) and the general observation that hydrophobic segments
form helices in membranes. In addition, the glycine at position 25, in
the second turn region, corresponds with the fact that this is the most
likely type of residue to terminate a helix in known protein structures
(Richardson and Richardson, 1988).
RESULTS
As described in Materials and Methods, Fig. 2 shows the basic
secondary structure predicted for a membrane-bound A3P[l-
40] molecule. The blue and red letters indicate the positive and
negatively charged residues, respectively. As can be seen from
the alternating pattern, the ,3-hairpin structure would be am-
phipathic, with the hydrophilic E3, R5, Eli, and H13 residues
projecting from one side, and the hydrophobic A2, F4, Y10, and
V12 residues projecting from the other side. Following a small
linker is the relatively short middle helix. Although hydrophobic
in the center, this helix has a positively charged residue (K16)
at the N-terminal end and two negatively charged residues (E22
and D23) at the C-terminal end. Finally, the N27 residue forms
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FIGURE 2 Secondary structure prediction for a membrane-bound A(3P
molecule. The red and yellow rectangles indicate the 13-strands of the hair-
pin, and the large cyan and blue cylinders indicate the middle and C-terminal
helices, respectively. The blue and red letters indicate the positive and nega-
tively charged residues, respectively. The four glycines in the C-terminal
helix are highlighted in yellow. (Although not clear in the figure, the second
half of the A2 residue is actually part of the (3-hairpin structure.)
the N-terminal cap of the more hydrophobic C-tenninal helix,
which comprises the remainder of the sequence. As also seen in
the figure, the four glycine residues (G29, 33, 37, and 38) are
stacked above each other. Because these residues are devoid of
side chains, they expose the backbone atoms along one side of
the helix.
Type I models
Fig. 3 shows schematic side and top views of a parallel Type I
channel formed from six identical A(3P subunits, as it would be
embedded in a membrane. The red and yellow rectangles indi-
cate the (3-strands, the cyan cylinders indicate the middle helices,
and the blue cylinders indicate the C-terminal helices. This is
described as a parallel structure because each subunit is oriented
in the same direction. The pore is formed by the 6 (3-hairpins,
which results in a 12-stranded, antiparallel (3-barrel. The lining
of the pore is formed from the charged and polar-neutral Dl
(including the (NH3)+ group), E3, R5, D7, S8, Ell, H13, and
H14 residues, which form salt-bridge and hydrogen bond net-
works. If not all the histidines are protonated, which is likely at
the experimental conditions ofpH 7.0 (Arispe et al., 1993b) and
7.4 (Arispe et al., 1993a), then the pore would have a net negative
charge. This would explain the cation selectivity of the channels
observed in vitro (Arispe et al., 1993a, b; Pollard et al., 1993).
Above the pore are the six middle helices arranged in a circle,
parallel to the membrane plane. Because they contain both
charged and nonpolar residues, they are embedded in the top
headgroup layer of the membrane where both hydrophilic and
hydrophobic contacts can be made. The head-to-tail arrangement
stabilizes the aggregate channel structure by forming comple-
mentary electrostatic interactions between the dipolar ends. In
addition, each K16 residue forms a stabilizing salt-bridge with
the D23 residue of the adjacent subunit, and each E22 residue
forms a salt-bridge with the K28 residue of the same subunit (not
shown). Finally, the pore is surrounded by the six hydrophobic
C-tenminal helices, which transverse the membrane core. Al-
though not providing a complete barrier, these helices serve to
anchor and shield the pore from the disruptive motions of the
lipids.
As shown in Fig. 4, an antiparallel version of the Type I chan-
nel can be formed from 12 identical AA3P subunits. The structure
can be thought of as two 6-subunit parallel channels (Fig. 3)
arranged tail-to-tail. The pore is formed by the two 12-stranded
antiparallel (3-barrels arranged in tandem. The middle helices,
which are embedded in the headgroup layers, form stabilizing
6-membered rings on both sides of the membrane. The pore is
surrounded by the 12 hydrophobic C-terminal helices, which are
interlaced in an antiparallel fashion. This provides a denser bar-
rier between the pore and the lipids than in the parallel model.
Also, in contrast, the antiparallel channel provides a symmetric
profile for the conduction of ions across the membrane.
In these models, the size of the pore is determined by the
number ofA,BP subunits incorporated into the complex. In Fig.3,
the minimum radius of the 6-subunit parallel Type I channel is
2.7 A. However, the actual width of the pore may differ because
of interactions with the solvent.A similar channel built with only
four A,BP subunits was found to have a minimum pore radius of
1.4 A (not shown). Because the channels with the smallest con-
duction were able to pass cations as large as Cs' (Arispe et al.,
1993b), which has an ionic radius of -1.7 A, it would seem that
four or five A,BP subunits is the minimum number required to
form an active, parallel Type I channel. However, we suspect
that a 4-subunit, 8-stranded (-barrel pore would be too small to
accommodate the large number ofcharged residues in the lining.
Larger pores are favored because they allow for more water
molecules to solvate the charges. The channels were also found
to be blocked reversibly by tromethamine and irreversibly by
Al3+ (Arispe et al., 1993a, b; Pollard et al., 1993). The action of
tromethamine is understandable considering its relatively large
size in relation to the pore width. However, the blocking action
of A13+, which has a relatively small ionic radius (-0.5 A) is
more difficult to interpret. One possibility is that the high charge
density causes one or more of these ions to bind tightly to the
negatively charged residues of the pore lining (i.e., Dl, E3, D7,
or Ell).
Type 11 and Ill models
Fig. 5 displays schematic side and top views of the type II chan-
nel formed from four A,BP subunits. In this model, the pore is
in the shape of a funnel, with the "cone" formed by the middle
helices (cyan cylinders) and lipid headgroups (dark gray
spheres) and the "spout" formed by the long C-terminal helices
(blue cylinders). The C-terminal helices are oriented such that
the glycine-containing faces (see Fig. 2) are toward the center.
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FIGURE 3 Schematic side (a) and top (b) views of the par-
allel Type I channel. The color code is the same as in Fig. 2.
The front C-terminal helix in the side view was truncated to
expose the ,3-barrel.
Because glycine residues lack bulky side chains, the helices are
able to pack closely while maintaining a reasonably sized pore
radius (-2.5A). In addition, the lack of a side chain exposes the
partial negatively charged carbonyl oxygen atoms of the peptide
backbone. Although not in the same KL,D)-helix confonnation
(Nicholson and Cross et al., 1989), this provides a cation-
selective environment similar to gramicidin A (Gennis, 1989).
Because the middle helices are at a 450 angle to the membrane
plane, Fig. 5 also shows how the charged phosphatidylserine
lipid headgroups (dark gray spheres) would naturally fall into
the four wedge-shaped spaces between them. This association is
stabilized by salt-bridges with the positively and negatively
charged K16, E22, and D23 residues. In this way, the charged
headgroups become part of the pore lining, where they would
affect the ion selectivity of the channel. Finally, the hydrophobic
sides of the four amphipathic 13-hairpins are used to cover the
alkyl chains of the channel-incorporated lipids, which would
otherwise be exposed to solvent because of their nonperpen-
dicular orientation with respect to the membrane plane.
The Type III channel is shown in Fig. 6. As seen from the
2-subunit side views in Fig. 7, the Type III channel is formed
from a concerted conformational change of the Type II chan-
nel, in which the hydrophobic C-terminal helices (blue cyl-
inders) move from a transmembrane orientation to a parallel
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FIGURE 4 Schematic side (a) and top (b) views
of the antiparallel Type I channel. The color code
is the same as in Fig. 2. The front C-terminal helices
in the side view were truncated to expose the
tandem 1-barrels.
position in the bottom alkyl-chain layer of the membrane.
The helices are oriented such that the semi-hydrophilic,
glycine-containing edge, which formed the lining of the
pore in the Type II model, is at the mixed polarity alkyl-
chain/headgroup interface. In the Type III channels, the
pore is formed exclusively by the four middle helices
(cyan cylinders) and the lipid headgroups (dark gray
spheres) that were bound in the Type II model (see Fig.
5). For the specific structure shown in Fig. 6, the mini-
mum radius of the pore is 3.0 A. However, larger or
smaller sizes could easily result from small adjustments
of the peptide/lipid interactions. As also shown in Fig. 6,
the alkyl-chains of the incorporated lipids (light gray
spheres), which are parallel to the membrane plane, are
shielded by the amphipathic ,B-hairpins on the top side of
the membrane and by the hydrophobic residues of the
C-terminal helices on the bottom side.
DISCUSSION
Our procedures have resulted in three basic types of A,BP
channel models, which are distinguished by the orientation
of the subunits in the membrane, and thus the portion of the
amino acid sequence that forms the pore lining. Although the
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FIGURE 5 Schematic side (a) and top (b) views of the Type
II channel. The dark and light gray spheres indicate the head-
groups and alkyl chains of the lipid molecules incorporated into
the channel structure. The color code for the protein is the same
as in Fig. 2.
models were computer-built at the atomic scale, they should
only be considered as representative of basic structural mo-
tifs. For instance, for any specific assembly pattern, it is
usually possible to rearrange the side-chain conformations
and thus form different networks of salt-bridges and hydro-
gen bonds. This is especially true for the incorporated lipid
molecules, which have many degrees of freedom
Experimentally, it has been demonstrated that active
channels can be formed when AI3P[1-40] is incorporated
into the bilayer by either the liposome fusion technique
or directly from solution (Arispe et al., 1993a, b; Pollard
et al., 1993). We envision two basic mechanisms by
which the A3P molecules would bind to the membrane
and rearrange to form the channel structures. In the first
mechanism, the Af3P molecules would initially bind to
one side of the membrane and diffuse to form a 2-D lat-
tice, or raft-like structure, on the surface. The am-
phipathic "raft" would be embedded in the headgroup
layer of the membrane such that the nonpolar residues
would be in contact with the alkyl chains at the bottom,
and the polar residues would be in contact with the lipid
headgroups and solvent at the top. It is then imagined that
the "raft" structure would fold in half such that the middle
section would be pushed through to the opposite side of
the membrane. Concurrently, both sides would curve
around the transmembrane axis to form a cylindrical,
Type I channel (Figs. 3 and 4). By this concerted
conformational change, the charged residues of the
3-hairpins move from the top side of the membrane to the
lining of the pore without having to be exposed to the
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FIGURE 6 Schematic side (a) and top (b) views of the
Type III channel. The color code is the same as in Fig. 5.
hydrophobic alkyl-chains of the lipids, which would be
energetically disfavored. Whether a parallel or antipar-
allel Type I channel is formed would depend on the sym-
metry of the initial lattice structure. A similar raft inser-
tion mechanism was illustrated for the 8-hemolysin
peptides (Raghunathan et al., 1990).
The second mechanism assumes that each Af3P mol-
ecule has inserted individually into the membrane, with
the amphipathic ,3-hairpin and middle helix in the head-
group layer and the hydrophobic C-terminal helix in a
transmembrane position. The next step would be the as-
sociation of four or more subunits into a ring, excluding
lipid molecules from the center. At this stage, the for-
mation of the parallel Type I and Type II channels are
both possible. A Type I channel would result simply from
the 13-hairpins folding into the center of the ring and form-
ing the 13-barrel pore. Similarly, the Type II channel
would result form the transmembrane C-terminal helices
packing with their glycine-containing sides oriented to-
ward the center. As discussed above, a Type III channel
could then be formed from a concerted conformational
change of the Type II channel (see Fig. 7).
It has also been observed experimentally that a single A13P
channel can undergo transitions between a number of dif-
ferent conduction states in the pico- ("large") and nanosi-
emens ("giant") ranges (Arispe et al., 1993a, b; Pollard et al.,
1993). One possible explanation is that this is because of
conversions between the TypeHandType HI channel structures,
which have different intrinsic pore sizes. In addition, the exact
size of the pore would be affected by random variations in the
protein and lipid binding conformations after each transition. An
alternative explanation, which also includes the Type I channels,
is that the change in pore size is caused by the rapid incorporation
or elimination of A1BP subunits. This could happen on a single
subunit basis or by the coalescence or separation of two mul-
tisubunit channel structures.
The channel models presented here are useful because they
explore a number of possibilities and suggest experiments to
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FIGURE 7 Simplified, two-subunit side views illustrat-
ing the conformational transition from the Type 11 (a) to *l __
Type III (b) channel structures. The color code is the same
as in Fig. 2.
determine the real channel structures. In turn, the results of these
experiments should advance the general understanding of ion
channels formed from other membrane bound peptides and small
proteins. Probably the most direct approach to detenrining the
structure would be to study membrane-bound ABP with solid-
state NMR and/or electron cryo-microscopy methods. Failing
these, a less direct approach would be to examine the effects of
sequence mutations and changes in environmental conditions on
the properties of the channels. For example, the presence of the
Type I motifcould be verified by examining the effects ofamino
acid substitutions in the 13-hairpin region of the sequence. One
possible experiment would be to neutralize the negative elec-
trostatic charge of the Dl, E3, D7, and/or Eli residues by sub-
stitution to either asparagine or glutamine, as appropriate. If the
pore of the channel is indeed formed by the 13-hairpins, then this
type of mutation would either reduce or eliminate the cation
selectivity. Likewise, a similar effect should be observed by low-
ering the solution pH below the pKa of the histidine residues,
which would effectively neutralize the net charge of the putative
13-barrel pore. On the other hand, these perturbations would have
little or no effect on the conduction properties of Type H or III
channels, where the pore is formed by the middle and/or
C-terminal helices. If the results point to the Type I motif, then
the parallel or antiparallel type structure could be distinguished
by determining whether the conduction and drug binding prop-
erties are symmetric with respect to both sides of the membrane.
As mentioned in Results, the antiparallel Type I model provides
a symmetric profile across the membrane, whereas the parallel
version does not.
Previously, we have discussed the possible connection
between the "giant" nanosiemens (nS) conductance of the
APP[1-40] channels observed in artificial bilayers with
the death of neurons in Alzheimer's disease (Arispe et al.,
1993a, b; Pollard et al., 1993). This view is supported by
the fact that Af3P added to neuron tissue culture has been
observed to disrupt [Ca2"]i homeostasis (Joseph and Han,
1992; Barger et al., 1993), which itself has been associ-
ated with cell death (Hardy and Higgins, 1992; Mattson
et al., 1992; Kimura and Schubert, 1993). If this theory
proves true, then the ion channel models would be useful
for designing inhibitory drugs.
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